Coverage
-
September 04, 2012
Agios Pharmaceuticals Inc. and Celgene Corp. have agreed to settle two lawsuits brought by the University of Pennsylvania in New York federal court over a former university researcher's alleged use of more than $1 billion worth of patentable, university-funded cancer research to form Agios, the companies announced Friday.
1 other articles on this case.
View all »